Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study

QR Code

Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study

Background: There is currently insufficient evidence to support the use of lipid-lowering drug treatment (LLT) for primary prevention of cardiovascular disease (CVD) in the elderly. Objectives: We examined the relationship of early initiation of LLT with short- and long-term all-cause and CVD mortal...

Full description

Bibliographic Details
Main Authors:	Ho, C., Chowdhury, E., Breslin, M., Doust, J., Reid, C., Wing, L., Nelson, M., Beilin, L., Jennings, G., Johnston, C., Macdonald, G., Marley, J., McNeil, J., Morgan, T., Reid, Christopher, Ryan, P., West, M.
Format:	Journal Article
Published:	Elsevier Inc. 2018
Online Access:	http://hdl.handle.net/20.500.11937/73927

Similar Items

Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017)

POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017)

Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018)

Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population
by: Huynh, Q., et al.
Published: (2015)

SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)

Predictive Performance of Echocardiographic Parameters for Cardiovascular Events Among Elderly Treated Hypertensive Patients
by: Chowdhury, E., et al.
Published: (2016)

Predictive performance of echocardiographic parameters for cardiovascular events among elderly treated hypertensive patients
by: Chowdhury, E., et al.
Published: (2016)

Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives
by: Dart, A., et al.
Published: (2008)

The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)

TEN-YEAR LEGACY EFFECTS OF BASELINE BLOOD PRESSURE TREATMENT NAIVETY IN THE SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY.
by: Nelson, M., et al.
Published: (2015)

Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study
by: Nelson, M., et al.
Published: (2015)

Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive population
by: Chowdhury, Enayet, et al.
Published: (2018)

Relation of Alcohol Consumption to Risk of Heart Failure in Patients Aged 65 to 84 Years With Hypertension
by: Sahle, B., et al.
Published: (2018)

A SCORE FOR THE PREDICTION OF CARDIOVASCULAR EVENTS IN THE HYPERTENSIVE AGED
by: Nelson, M., et al.
Published: (2011)

A score for the prediction of cardiovascular events in the hypertensive aged
by: Nelson, M., et al.
Published: (2012)

Pet ownership and survival in the elderly hypertensive population
by: Chowdhury, E., et al.
Published: (2016)

Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)

Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality
by: Freak-Poli, R., et al.
Published: (2021)

Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)

Prediction of 10-year risk of incident heart failure in elderly hypertensive population: The ANBP2 study
by: Sahle, B., et al.
Published: (2017)

Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020)

Cardiovascular risk prediction in healthy older people
by: Neumann, J.T., et al.
Published: (2022)

Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

NIGHT-TIME AMBULATORY BLOOD PRESSURE IS THE BEST PRETREATMENT BLOOD PRESSURE PREDICTOR OF 11-YEAR MORTALITY IN OLDER HYPERTENSIVES
by: Wing, L., et al.
Published: (2017)

Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
by: Wing, L., et al.
Published: (2018)

Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
by: Dhaliwal, Satvinder, et al.
Published: (2017)

Australians at Risk: Management of Cardiovascular Risk Factors in the REACH Registry
by: Reid, Christopher, et al.
Published: (2008)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: Protocol for a randomised controlled trial in primary care (STAREE trial)
by: Zoungas, S., et al.
Published: (2023)

Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)

PREDICTIVE PERFORMANCE OF ECHOCARDIOGRAPHIC PARAMETERS ON CARDIOVASCULAR EVENTS AMONG THE ELDERLY TREATED HYPERTENSIVE PATIENTS
by: Chowdhury, E., et al.
Published: (2015)

Association of depression with mortality in an elderly treated hypertensive population
by: Chowdhury, E., et al.
Published: (2018)

Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: A Cross-sectional Study
by: Chowdhury, Enayet, et al.
Published: (2020)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older persons
by: Liew, S.M., et al.
Published: (2022)

Applying a framework to assess the impact of cardiovascular outcomes improvement research
by: Sarkies, Mitchell, et al.
Published: (2021)

Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort
by: Nelson, M., et al.
Published: (2009)

Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
by: Islam, R.M., et al.
Published: (2022)

Short-and long-term survival in treated elderly hypertensive patients with or without diabetes: Findings from the second Australian national blood pressure study
by: Chowdhury, E., et al.
Published: (2014)